Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Jitendra Kumar PalDesignation :- Company Secretary and Compliance Officer Announcement under Regulation 30 (LODR)-Appointment of Interim Resolution Professional (IRP)
This is to inform you that, Honorable NCLT, Chennai vide Order No.CP/682/(IB)/CB/2017 dated 16th July 2018, received by the Company on 18th July 2018 has admitted the reference for initiation of Corporate Insolvency resolution process under Section 9 of The Insolvency and Bankruptcy Code, 2016(IBC). By the said order NCLT, Chennai has appointed Mr.Gopalsamy Ganesh Babu as an Interim Resolution Professional (IRP) under the provisions of IBC.... Financial Results 31-03-2018
The Audited Financial results for the quarter and Year ended 31st March 2018 has been adopted and approved by the Audit Committee and Board of Directors in the meeting held today. Board Meeting-Appointment of Company Secretary / Compliance Officer
We wish to inform you that the Nomination & Remuneration Committee of the company recommended to appoint Mr. Jitendra Pal, Company Secretary. The Board of Directors in their meeting held on 28th May, 2018 has appointed Mr. Jitendra Pal, as the Company Secretary and Compliance Officer of the Company with effect from 01st June 2018 . Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, We wish to inform you that, the Board of Directors of the Company in their meeting held on Monday, the 28th May, 2018 has considered & approved the resignation of Ms. Nirmala L, Company Secretary from the company and she will be relieved from the services of the Company with effect from 31st May 2018. Announcement under Regulation 30 (LODR)-Resignation of Director
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, We wish to inform you that, the Board of Directors of the Company in their meeting held on Monday, the 28th May, 2018 has considered & approved the resignation of the following Directors: 1. Mr. B Kamlesh Kumar, Director with effect from 20th May 2018(Date of Resignation).... Board Meeting-Outcome of Board Meeting
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that, the Board of Directors of the Company in their meeting held on Monday, the 28th day of May, 2018 which commenced at 3.30 PM and concluded at 7.00 PM, inter alia transacted the following: 1. Considered and approved Financial Statements for the year ended 31st March, 2018.... Reconstitution Of Audit Committee
The Audit Committee of the Company has been reconstituted as follows: Mr. V Rajamani - Chairman Mr. R Dwarkanathan - Member Mr. Sunil Bafna - Member Mr. Mahaveer Chand Bafna- Member Intimation Of Approval Of MHRA.
Pursuant to the audit conducted by Medicines and Healthcare products Regulatory Agency (MHRA), our FACILITY has got RENEWAL approval as per the Guidelines of European Good Manufacturing Practices (EUGMP).